| Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ... Science 377 (6603), eabq1841, 2022 | 299 | 2022 |
| Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 I McDonald, SM Murray, CJ Reynolds, DM Altmann, RJ Boyton npj Vaccines 6 (1), 74, 2021 | 245 | 2021 |
| Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Science immunology 5 (54), eabf3698, 2020 | 199 | 2020 |
| Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. DJ Pinato, SM Murray, A Forner, T Kaneko, P Fessas, P Toniutto, ... Journal for immunotherapy of cancer 9 (9), 2021 | 101 | 2021 |
| The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses SM Murray, AM Ansari, J Frater, P Klenerman, S Dunachie, E Barnes, ... Nature Reviews Immunology 23 (5), 304-316, 2023 | 86 | 2023 |
| Examining the immunological effects of COVID-19 vaccination in patients with conditions potentially leading to diminished immune response capacity–the OCTAVE trial P Kearns, S Siebert, C Gaskell, A Kirkham, S Pirrie, S Bowden, ... | 69 | 2021 |
| Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study RK Gupta, J Rosenheim, LC Bell, A Chandran, JA Guerra-Assuncao, ... The Lancet Microbe 2 (10), e508-e517, 2021 | 58 | 2021 |
| SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease E Barnes, CS Goodyear, M Willicombe, C Gaskell, S Siebert, T I de Silva, ... Nature medicine 29 (7), 1760-1774, 2023 | 56 | 2023 |
| Chlamydia trachomatis: Cell biology, immunology and vaccination SM Murray, PF McKay Vaccine 39 (22), 2965-2975, 2021 | 55 | 2021 |
| Immunotherapy in hepatocellular carcinoma CAM Fulgenzi, T Talbot, SM Murray, M Silletta, B Vincenzi, A Cortellini, ... Current Treatment Options in Oncology 22, 1-19, 2021 | 35 | 2021 |
| HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19 S Astbury, CJ Reynolds, DK Butler, DC Muñoz‐Sandoval, KM Lin, ... Immunology 166 (1), 68-77, 2022 | 24 | 2022 |
| Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... Med 4 (3), 191-215. e9, 2023 | 20 | 2023 |
| Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant SM Murray, M Barbanti, C Campbell, A Brown, L Chen, J Dhanapal, ... British Journal of Haematology 198 (4), 668-679, 2022 | 17 | 2022 |
| COVIDsortium investigators; COVIDsortium immune correlates network, Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Sci. Immunol 5, 2020 | 10 | 2020 |
| Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... MedRxiv, 2022.06. 06.22275865, 2022 | 8 | 2022 |
| Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients SM Murray, E Pose, M Wittner, MC Londoño, G Schaub, J Cook, ... Journal of Hepatology 80 (1), 109-123, 2024 | 3 | 2024 |
| Humoral and cellular immune responses to wild-type and omicron (B. 1.1. 529) SARS-CoV-2 variants following a fourth COVID-19 vaccination in liver transplant recipients and … S Dimitriadis, G Meacham, S Irwin, V Walker, S Murray, Z Lim, T Marjot, ... Journal of Hepatology 77, S58, 2022 | 2 | 2022 |
| Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label … CS Goodyear, A Patel, E Barnes, M Willicombe, S Siebert, TI de Silva, ... The Lancet Rheumatology 6 (6), e339-e351, 2024 | 1 | 2024 |
| T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1. 1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver … S Murray, S Longet, T Tipton, MC Londoño, E Pose, S Laidlaw, D Nguyen, ... Journal of Hepatology 77, S57, 2022 | 1 | 2022 |
| Humoral and cellular immune responses to SARS-CoV-2 vaccination across multiple vaccine platforms and liver disease types: an EASL registry multicentre prospective cohort study T Marjot, S Murray, E Pose, Z Lim, MC Londoño, M Wittner, ... Journal of Hepatology 77, S54, 2022 | 1 | 2022 |
